John Cunningham

Partner, London


A corporate finance partner with extensive experience of the infrastructure and healthcare sectors.


John Cunningham is a partner in our global M&A and Corporate practice based in London with a particular focus on the infrastructure sector.

John has a broad corporate and transactional practice, including corporates, banks, private equity houses and funds on a multitude of complex cross-border transactions. He counts a number of high-profile deals among his successes, including, in the infrastructure space, RWE AG's €1.6 billion disposal of NET4GAS and EPH's acquisition of Eggborough Power Plant, and in the healthcare sector, Bupa's acquisition of Poland's leading healthcare provider.

During his career, John spent nine months on secondment to GlaxoSmithKline's legal department, spending time in the UK and US working on a wide variety of matters, with a particular focus on M&A and global procurement.

Bars and Courts
England and Wales
College of Law, London
College of Law, London
Oxford University


Wren House's acquisition of stake in GPG
Represented Wren House, the infrastructure investment arm of the Kuwait Investment Authority, on its acquisition of a 25% stake in GNF's global power generation portfolio, GPG.

EPH's acquisition of Eggborough power station, 2014
Represented Energetický a průmyslový holding (EPH) in its agreement to buy Eggborough power station in North Yorkshire from a consortium led by Strategic Value Partners.

Limak's €285 million disposal, 2014
Represented Limak in the €285 million sale of its 40% stake in Istanbul’s Sabiha Gokcen International Airport to Malaysia Airports Holdings Bhd.

Alpha Trains' purchase of a rolling stock portfolio, 2013
Represented Alpha Trains in the acquisition of 202 Pan-European rolling stock assets from the Royal Bank of Scotland, in a combined asset and share sale transaction. The deal was particularly complex, since the assets are operational across 12 European jurisdictions.

Novartis investment in Oxford Biomedica plc, 2014
Represented Novartis in its USD$14 million collaboration with Oxford Biomedica including LentiVector® licence agreement.

RWE's €1.6 billion disposal, 2013
Represented RWE AG in the €1.6 billion sale of NET4GAS, s.r.o., the Czech gas transmission system operator, to a consortium of Allianz Capital Partners and Borealis Infrastructure Management Inc, the Canada-based infrastructure arm of OMERS.

Bupa's €400 million acquisition of LuxMed, 2012
Advised Bupa, the international healthcare and health insurance group, on its €400 million acquisition of LUXMED Group, Poland's largest private healthcare services provider, from Mid Europa Partners.

Autostrade per l’Italia's partial disposal in Chile, 2012
Acted for Autostrade per l'Italia, a subsidiary of Italian motorway operator Atlantia, on the €857 million (US$1.13 billion) sale of a 49.99 percent stake in Grupo Costanera, its Chilean unit - which owns five toll roads in Chile - to the Canada Pension Plan Investment Board.

Seabed to surface engineering merger, 2011
Represented NASDAQ- and Oslo Stock Exchange-listed Acergy S.A. in its combination with Oslo Stock Exchange-listed Subsea 7 Inc., to create a US$8.8 billion global leader in seabed-to-surface engineering and construction.

Awards and Recognition

Emerging Leaders Awards winner, M&A Advisor, 2015